Regents of the University of California’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Regents of the University of California’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,200	Closed	-$421K	–	26
2017 Q1	$421K	Sell	4,200 -4,200	-50%	-$449K	2.06%	17
2016 Q4	$903K	Sell	8,400 -4,200	-33%	-$491K	3.21%	11
2016 Q3	$1.57M	Buy	+12,600	New	+$1.49M	4.48%	6

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Regents of the University of California's CBPO Position: Q2 2017 in Review

Regents of the University of California sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 4,200 shares — an estimated $421K sold.

Regents of the University of California first reported a position in CBPO in Q3 2016 and held it in 3 quarters. The position peaked at $1.57M in Q3 2016. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

Regents of the University of California reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
Regents of the University of California sold 4,200 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $421K.
Regents of the University of California first reported a position in China Biologic Products Holdings, Inc. in Q3 2016 and held it in 3 quarters.
Regents of the University of California's China Biologic Products Holdings, Inc. position peaked at $1.57M in Q3 2016.
119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Regents of the University of California's 13F filing for Q2 2017, filed 21 Aug 2017.